Evidence map›Paper›PMID 28415952›Full record

ArticleThe Journal of international medical research2017

Effective treatment of ketamine-associated cystitis with botulinum toxin type a injection combined with bladder hydrodistention.

Jianfeng Zeng, Haibiao Lai, Dongxiang Zheng, Liang Zhong, Zhifeng Huang, Shanyun Wang, Weiwei Zou, Lianbo Wei

Open access · goldAbstract read
In one paragraph

Article in The Journal of international medical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Jianfeng Zeng1 College of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
Haibiao Lai2 Department of Urology Surgery, Hospital of Traditional Chinese Medicine of Zhongshan, Zhongshan, China.
Dongxiang Zheng2 Department of Urology Surgery, Hospital of Traditional Chinese Medicine of Zhongshan, Zhongshan, China.
Liang Zhong2 Department of Urology Surgery, Hospital of Traditional Chinese Medicine of Zhongshan, Zhongshan, China.
Zhifeng Huang2 Department of Urology Surgery, Hospital of Traditional Chinese Medicine of Zhongshan, Zhongshan, China.
Shanyun Wang3 Department of Obstetrics and Gynecology, Hospital of Traditional Chinese Medicine of Zhongshan, Zhongshan, China.
Weiwei Zou4 Department of Anesthesiology, Zhongshan Torch Development Zone Hospital, Zhongshan, China.
Lianbo Wei1 College of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.
Zhongshan Hospital · CNSouthern Medical University · CNGuangzhou Development Zone Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Ketamine-associated cystitis (KAC) has been described in a few case reports, but its treatment in a relatively large number of patients has not been documented. This study aimed to describe our experience of treatment of 36 patients with KAC. Methods Thirty-six patients (30 males and 6 females, aged 19-38 years) with KAC, who had previously taken a muscarinic receptor blocker and/or antibiotics, but without symptomatic relief, were treated with botulinum toxin A injection combined with bladder hydrodistention. Urodynamic testing, and the O'Leary-Sant interstitial cystitis symptom index (ICSI) and problem index (ICPI) were used to evaluate baseline values and improvement before and after the treatment. Results One month post-treatment, all patients achieved marked relief of symptoms. The nocturia time was markedly reduced, while bladder capacity, the interval between micturition, the void volume, and the maximum flow rate were remarkably increased at 1 month. Additionally, the ICSI and ICPI were significantly improved. Conclusion Botulinum toxin A injection along with bladder hydrodistention is effective for managing KAC.

Indexed as

AdultAnesthetics, DissociativeBotulinum Toxins, Type ACystitisFemaleHumansHydrotherapyKetamineMaleProspective StudiesTissue ExpansionTreatment OutcomeUrinary BladderUrinationUrodynamicsAnesthetics, DissociativeBotulinum Toxins, Type AKetaminebotulinum toxin AhydrodistentionKetamine-associated cystitisurodynamic testing

Identifiers

PMID28415952
PMCPMC5536663
OpenAlexW2592482445

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.